Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

Wed, 13th Apr 2022 19:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ediston Property Investment Co PLC - Edinburgh-based real estate investment company - Confirms sale of leisure asset at The Lanyard, Hartlepool, which is let to Mecca Bingo Ltd for GBP2.6 million, which is 16% above its most recent valuation at December 31.

----------

SulNOx Group PLC - London-based supplier of fuel conditioners - Receives certification for SulNOxEco Fuel Conditioner from Lloyd's Register Fuel Oil Bunker Analysis and Advisory Service. Lloyds found the fuel had minimal impact on ISO 8217 test parameters, without changing characteristics when added to machine fuel at the prescribed dosage rate. "Lloyd's Register is a highly respected and trusted international classification society and these results provide another significant landmark for SulNOx marine," says Nicholas Fairfax, non-executive director & Marine lead.

----------

Europa Oil & Gas (Holdings) PLC - Ireland and Morocco focused oil and gas exploration and production company - Records strongest interim performance since the first half of 2014, as revenue rises to GBP2.2 million in the six months to January 31, from GBP500,000 a year before. Swings to pretax profit of GBP700,000 from pretax loss of GBP700,000 a year prior. Attributes performance to its 30% interest in Wressle oil field in North Lincolnshire, which delivered beyond expectations.

----------

Value & Indexed Property Income Trust PLC - London-based investment manager for UK commercial properties - Says direct commercial property portfolio increases to GBP155.5 million at March 31, up from GBP110.5 million at September 30. VIP's property portfolio delivers total return of 8.8% over the six months to March 31, and 20% over the past year. " VIP is now almost fully invested after its transition to a predominantly property trust," it notes.

----------

McKay Securities PLC - South East and London-focused office property investor - Says board continues to unanimously recommend the takeover offer from Workspace Group PLC, following Tuesday's news that Canadian private equity firm Slate Asset Management did not intend to make an offer.

----------

Lekoil Ltd - oil and gas exploration and production company focused on Nigeria and West Africa - Notes the announcement from Lekoil Nigeria Ltd that it spuds the Otakikpo-4 well as part of its Phase 2 development at Otakikpo. Lekoil Nigeria also renews the Otakikpo offtake agreement with Shell Western Supply & Trading Ltd.

----------

IOG PLC - London-based gas and infrastructure operator with projects in the North Sea - Says fault at Blythe well "temporarily addressed" and the well reopened on Tuesday. "A further permanent modification on the Blythe platform has been designed and will be installed when materials are available. This permanent modification is not anticipated to involve material downtime," IOG says.

----------

Watchstone Group PLC - cash shell with remaining assets comprising litigation assets, contingent liabilities and cash - Says subsidiary WTGIL Ltd's dismissed in first-tier tribunal, with the ruling in favour of HMRC. Case concerns supplies of telematic devices or related services during VAT period 2014-2018. "WTGIL will consider the judgment with its advisers and counsel and decide on the next steps (if any) including whether to appeal to the Upper Tax Tribunal," it says.

----------

Open Orphan PLC - Notes announcement from Poolbeg Pharma PLC regarding numerous new investors expressing interest in acquiring up to GBP1.6 million of company's shares which are currently locked-up and held in trust by Croft Nominees Ltd, following the distribution in specie from Open Orphan PLC in June last year. "This arrangement has followed significant efforts to help widen the Poolbeg investor base and increase future liquidity, in order to ensure that the dividend in specie remains as beneficial as possible to shareholders of both Open Orphan and Poolbeg in the long-term," says Executive Chair Cathal Friel.

----------

Harland & Wolff Group Holdings PLC - Belfast-based offshore construction company - Says wholly-owned subsidiary Harland & Wolff (Arnish) Ltd wins fabrication contract at roll twelve Super Duplex Shells for the Hinkley C nuclear power project, to finish by the end of June. Arnish is on track to complete suction pile contract announced in November, and making progress to launch the first of eight boat landings for the Saipem contract. Cumulative value of projects is in the region of GBP2 million to GBP3 million.

----------

Bradda Head Lithium Ltd - North America-focused lithium development company - Raises GBP2.0 million through UK placing of 14.5 million shares at 13.5 pence, having received orders in excess of GBP6.6 million. This comes in addition to the North American fundraise, which raised GBP9.9 million through 73.2 shares at the same price. Non-executive director subscribed for 834,226 placing shares, bringing his total holding to 65.0 million shares, or 17% of Bradda's ordinary share capital.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 11:45

Open Orphan's hVIVO wins GBP14.7 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said it's subsidiary hVIVO signed a GBP14.7 million contract for an influenza characterisation study and a follow on influenza human challenge study.

Read more
31 May 2022 16:05

UK earnings, trading statements calendar - next 7 days

Wednesday 1 June  
Impax Asset Management Group PLCHalf Year Results
Dr Martens PLCFull Year Results
Thursday 2 June  
no events scheduled 
Friday  3 June  
no events scheduled  
Monday 6 June  
Atrato Onsite Energy PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Jadestone Energy PLCFull Year Results
Tuesday 7 June  
Gooch & Housego PLCHalf Year Results
LXi REIT PLCFull Year Results
NewRiver REIT PLCFull Year Results
Open Orphan PLCFull Year Results
Schroder Real Estate Investment Trust LtdFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 16:43

Open Orphan's hVIVO wins GBP7.3 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said its subsidiary hVIVO Ltd has signed a GBP7.3 million contract.

Read more
18 May 2022 15:15

Open Orphan wins £7.3m human flu study contract

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.

Read more
6 May 2022 19:11

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 May 2022 14:53

IN BRIEF: Open Oprhan wins contract for vaccine field site study

Open Orphan PLC - London-based pharmaceutical services - Subsidiary hVIVO is awarded new study with existing unnamed pharmacetical client to act as vaccination site for the client's respiratory syncytial virus vaccine candidate. hVIVO's specialist arm FluCamp will recruit 60 healthy volunteers to the new site clinic at Plumbers Row where trials will take place.

Read more
1 Apr 2022 20:23

IN BRIEF: Open Orphan Covid study results published in Nature Medicine

Open Orphan PLC - London-based pharmaceutical services - Says Thursday that results from the world's first Covid-19 characterisation study have been peer reviewed and published in the scientific journal Nature Medicine. Says study showed the SARS-CoV-2 human challenge was safe in healthy young adults and provided insights into the course of Covid-19 infection with potential positive public health implications. With the characterisation study disease modelling data completed, and human challenge model established, Open Orphan says it should be able to conduct Covid-19 human challenge studies in 2022.

Read more
25 Mar 2022 14:10

IN BRIEF: Open Orphan wins GBP5 million human challenge study pact

Open Orphan PLC - London-based pharmaceutical services firm - Says its subsidiary, hVIVO, wins contract with a European biotechnology company for a human challenge study. The GBP5 million contract with a European biotech seeks to test hVIVO's intravenous antiviral candidate. The study on the respiratory syncytial virus is expected to commence this year. Revenue from the deal will be recognised across 2022 and 2023.

Read more
25 Mar 2022 09:39

Open Orphan wins £5m contract for human study in RSV

(Sharecast News) - Open Orphan announced on Friday that its hVIVO subsidiary has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with an unnamed European biotechnology company, to test its intravenous antiviral candidate.

Read more
8 Mar 2022 19:37

IN BRIEF: Open Orphan expects to report profitable 2021 performance

Open Orphan PLC - London-based pharmaceutical services - For 2021, expects to report earnings before interest, tax, depreciation and amortisation, on revenue which is set to be GBP40 million, up from GBP20.6 million in 2020. For 2022, the company is targeting GBP50 million in non-Covid work revenue.

Read more
24 Feb 2022 15:24

Open Orphan appoints Mo Khan as its new chief executive

(Sharecast News) - Contract research organisation Open Orphan announced the appointment of Yamin 'Mo' Khan as its chief executive officer on Thursday, with immediate effect.

Read more
24 Feb 2022 14:48

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Feb 2022 20:13

IN BRIEF: Positive results from Open Orphan human challenge study

Open Orphan PLC - pharmaceutical services provider - Sees positive results from a human challenge study assessing its respiratory syncytial virus antiviral candidate, EDP-938. Says results from the study have been published in The New England Journal of Medicine. hVIVO, a subsidiary of Open Orphan, conducted the Phase 2a, double-blind, placebo-controlled trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.